Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulating tumor ...
Health-related quality of life in metastatic hormone sensitive prostate cancer (mHSPC): Insights from a network meta-analysis of treatment options. Efficacy and safety of darolutamide versus ...
We conducted a systematic meta-analysis of 30 studies involving 3,287 patients with postoperative NSCLC to evaluate the diagnostic performance of ctDNA-based MRD testing for recurrence detection and ...
Early in tumor development, circulating tumor cells (CTCs) detach from primary or metastatic lesions and are important ...
Circulating tumor cells (CTCs) are malignant cells that have detached from primary or metastatic tumor sites and entered the peripheral bloodstream. As a critical component of liquid biopsy, the ...
Figure illustrating how circulating tumor cells (CTCs) evade immune defenses in the bloodstream by upregulating immune checkpoints, altering MHC class I expression, forming clusters, and interacting ...
Circulating tumor DNA (ctDNA) is emerging as a promising biomarker to predict treatment response in patients with metastatic renal cell carcinoma (mRCC). In a recent study, Alan Tan, MD, of Vanderbilt ...
Researchers utilize engraved polycarbonate sheets and antibody coatings to efficiently capture cancer cells in microchannels. (Nanowerk News) Circulating tumor cells (CTCs) refer to cancer cells that ...
An implantable scaffold and magnetic probes capture circulating tumor cells directly in the bloodstream, eliminating over 90% of captured cells in rabbits and goats. (Nanowerk Spotlight) A single ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results